Antimicrobial Silver Nanoparticles

Silver nanoparticles are widely studied as antimicrobial materials because they can act as nanoscale sources of biologically active silver ions. The observed antimicrobial response depends on particle size, shape, surface chemistry, dissolution behavior, concentration, and exposure conditions, so results from one silver nanoparticle formulation should not be assumed to apply to every material or biological system.

Research has explored silver nanoparticles in antibacterial, antiviral, wound-care, coating, and food-packaging applications. Understanding how nanoparticle properties influence silver ion release and interactions with the surrounding environment is important when selecting materials and comparing study results. Learn more about silver nanoparticle physical properties and silver nanoparticle safety.

How Silver Nanoparticle Properties Affect Antimicrobial Activity

Silver ion release is an important contributor to the antimicrobial behavior of silver nanoparticles. The rate and duration of ion release depend on the physical and chemical properties of the particle as well as the surrounding environment.

Several variables are particularly important when designing or interpreting antimicrobial studies:

• Particle size: Smaller particles have more surface area per unit mass and are often associated with greater silver ion release and stronger antimicrobial effects under otherwise similar conditions.
• Particle shape: Morphology changes exposed crystal surfaces, surface area, and interactions with the surrounding environment, which can influence particle dissolution and biological response.
• Surface chemistry: Capping agents and coatings affect colloidal stability, accessibility of the silver surface, interactions with biological molecules, and ion-release behavior.
• Formulation & exposure conditions: Concentration, pH, salts, proteins, temperature, exposure time, and the biological model can all influence the measured response.

These variables make well-characterized nanoparticles especially useful for comparative studies in which one particle property is changed while other parameters are controlled. See Nanotoxicology: Particle Selection for additional discussion of particle-property and dissolution effects.

Choosing Silver Nanoparticles for Antimicrobial Research

Particle Size, Shape & Surface

The appropriate silver nanoparticle depends on the research question. Studies focused on size-dependent behavior benefit from comparing particles with similar surface chemistry across multiple diameters, while studies investigating coating effects require careful control of particle size and formulation.

nanoComposix offers well-characterized silver nanomaterials across multiple particle sizes, morphologies, and surface chemistries. Current options include silver nanospheres and nanocubes, as well as silica-coated and other silver-containing particle architectures.

Low-Endotoxin Formulations

For cell culture and other sensitive biological research, selected silver nanosphere sizes are available at 1 mg/mL in low-endotoxin formulations that are passed through a 0.22 µm membrane filter in a controlled environment. These materials are batch tested for endotoxin and supplied with batch-specific characterization data.

Refer to the individual product page for current size, surface, concentration, and endotoxin specifications. Standard catalog materials are intended for research use.

Silver Nanoparticles in Antimicrobial Research

Silver has a long history of use in antimicrobial materials, while modern nanoparticle research has enabled researchers to investigate how nanoscale size, surface chemistry, and controlled ion release influence antimicrobial behavior. The literature includes studies across bacterial, viral, wound-care, and materials applications.

Antiviral & Immunomodulatory Research

Silver nanoparticles have been investigated against several viruses using a range of particle formulations and experimental models. Published studies have reported inhibitory effects involving HIV-1, hepatitis B virus, H1N1 influenza A virus, and transmissible gastroenteritis virus (TGEV).^1–5

In one study using nanoComposix silver nanoparticles, researchers evaluated respiratory syncytial virus (RSV) infection in epithelial cell culture and a BALB/c mouse model and reported changes in viral replication and inflammatory response.⁶ Other research has investigated silver-containing materials and coatings for infection-control applications.⁷

These findings are specific to the particle formulations, concentrations, biological models, and experimental conditions evaluated in each study and should not be interpreted as evidence of clinical efficacy for silver nanoparticles generally.

Antibacterial Effects & Wound-Care Research

Silver-containing materials have been extensively investigated for wound-care and antibacterial applications.⁸ Studies cited below include experiments involving Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), and other bacterial systems.^9–12

Researchers have also investigated how particle size, capping chemistry, concentration, and incorporation into other materials affect antibacterial performance. For example, studies using nanoComposix materials have evaluated capping-agent-dependent antimicrobial activity and size-dependent interactions with S. aureus.^10,11

Silver nanoparticles have additionally been investigated in wound-healing and controlled-release materials, including dressings and polymeric fiber systems.^13,16 Performance and safety depend on the complete formulation, release profile, exposure conditions, and intended use.

Food Packaging & Surface Coatings

Silver nanoparticles have also been investigated as antimicrobial components in polymeric materials and food-packaging systems.^14,15 Incorporating silver into a polymer can provide a means of controlling particle localization and silver release while adding antimicrobial functionality to the material.

Studies include silver-containing materials designed to inhibit food-associated microorganisms such as Listeria monocytogenes.¹⁷ For food-contact applications, nanoparticle migration, exposure, toxicology, and applicable regulatory requirements must be evaluated alongside antimicrobial performance.

Designing & Interpreting Silver Nanoparticle Studies

Antimicrobial performance should be interpreted in the context of both the nanoparticle and the test environment. Two samples with the same nominal silver concentration can behave differently if their particle size, surface chemistry, aggregation state, or dissolution behavior differs.

When comparing silver nanoparticle formulations, consider controlling or documenting:

• Primary particle size and size distribution
• Particle number and silver mass concentration
• Surface chemistry and residual formulation components
• Aggregation state in the relevant medium
• Silver ion release and exposure duration
• Biological model and assay conditions

Complementary characterization can help distinguish particle-dependent effects from changes caused by aggregation, dissolution, or formulation components. See Nanoparticle Characterization Techniques for an overview of TEM, DLS, zeta potential, UV-Visible spectroscopy, and related methods.

Selected Literature & Supporting References

† Studies using nanoComposix silver nanoparticles.

1. Galdiero, S.; Falanga, A.; Vitiello, M.; Cantisani, M.; Marra, V.; Galdiero, M. Silver Nanoparticles as Potential Antiviral Agents. Molecules 2011, 16, 8894–8918.
2. Lara, H. H.; Ayala-Nuñez, N. V.; Ixtepan-Turrent, L.; Rodriguez-Padilla, C. Mode of Antiviral Action of Silver Nanoparticles Against HIV-1. J. Nanobiotechnol. 2010, 8, 1.
3. Lu, L.; Sun, R. W.-Y.; Chen, R.; Hui, C.-K.; Ho, C.-M.; Luk, J. M.; Lau, G. K.; Che, C.-M. Silver Nanoparticles Inhibit Hepatitis B Virus Replication. Antivir. Ther. 2008, 13, 253–262.
4. Xiang, D.; Chen, Q.; Pang, L.; Zhang, C.-I. Inhibitory Effects of Silver Nanoparticles on H1N1 Influenza A Virus In Vitro. J. Virol. Methods 2011, 178, 137–142.
5. Lv, X.; Wang, P.; Bai, R.; Cong, Y.; Suo, S.; Ren, X.; Chen, C. Inhibitory Effect of Silver Nanomaterials on Transmissible Virus-Induced Host Cell Infections. Biomaterials 2014, 35, 4195–4203.
6. † Morris, D.; Ansar, M.; Speshock, J.; Ivanciuc, T.; Qu, Y.; Casola, A.; Garofalo, R. P. Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection. Viruses 2019, 11, 732.
7. Nakamura, S.; Sato, M.; Sato, Y.; Ando, N.; Takayama, T.; Fujita, M.; Ishihara, M. Synthesis and Application of Silver Nanoparticles (Ag NPs) for the Prevention of Infection in Healthcare Workers. Int. J. Mol. Sci. 2019, 20, 3620.
8. Hilfenhaus, P.; John, H.; Buettner, H. Antimicrobial Wound Dressing. United States Patent US 7,270,721, 2007.
9. Surwade, P.; Ghildyal, C.; Weikel, C.; Luxton, T.; Peloquin, D.; Fan, X.; Shah, V. Augmented Antibacterial Activity of Ampicillin with Silver Nanoparticles Against Methicillin-Resistant Staphylococcus aureus (MRSA). J. Antibiot. 2019, 72, 50–53.
10. † Niska, K.; Knap, N.; Kędzia, A.; Jaskiewicz, M.; Kamysz, W.; Inkielewicz-Stepniak, I. Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An In Vitro Study. Int. J. Med. Sci. 2016, 13, 772–782.
11. † Kang, J.; Dietz, M. J.; Hughes, K.; Xing, M.; Li, B. Silver Nanoparticles Present High Intracellular and Extracellular Killing Against Staphylococcus aureus. J. Antimicrob. Chemother. 2019, 74, 1578–1585.
12. Parvekar, P.; Palaskar, J.; Metgud, S.; Maria, R.; Dutta, S. The Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of Silver Nanoparticles Against Staphylococcus aureus. Biomater. Investig. Dent. 2020, 7, 105–109.
13. Gunasekaran, T.; Nigusse, T.; Dhanaraju, M. D. Silver Nanoparticles as Real Topical Bullets for Wound Healing. J. Am. Coll. Clin. Wound Spec. 2012, 3, 82–96.
14. Istiqola, A.; Syafiuddin, A. A Review of Silver Nanoparticles in Food Packaging Technologies: Regulation, Methods, Properties, Migration, and Future Challenges. J. Chin. Chem. Soc. 2020, 67, 1942–1956.
15. Carbone, M.; Donia, D. T.; Sabbatella, G.; Antiochia, R. Silver Nanoparticles in Polymeric Matrices for Fresh Food Packaging. J. King Saud Univ. Sci. 2016, 28, 273–279.
16. Mahdieh, Z.; Mitra, S.; Holian, A. Core–Shell Electrospun Fibers with an Improved Open Pore Structure for Size-Controlled Delivery of Nanoparticles. ACS Appl. Polym. Mater. 2020, 2, 4004–4015.
17. Belluco, S.; Losasso, C.; Patuzzi, I.; Rigo, L.; Conficoni, D.; Gallocchio, F.; Cibin, V.; Catellani, P.; Segato, S.; Ricci, A. Silver as Antibacterial toward Listeria monocytogenes. Front. Microbiol. 2016, 7, 307.
18. Casey, B. J.; Dair, B. J. Influence of Size on Antimicrobial Activity of Silver Nanoparticles. Adv. Sci. Eng. Med. 2015, 7, 112–119.

---

Related silver nanoparticle resources

• Introduction to Silver Nanoparticles
• Silver Nanoparticle Physical Properties
• Silver Nanoparticle Safety
• Nanotoxicology: Particle Selection
• Nanoparticle Characterization Techniques